AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab (November 14, 2006). doi:10.1152/ajpendo.00369.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/E802    most recent
00369.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barre, L.
Right arrow Articles by Witters, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barre, L.
Right arrow Articles by Witters, L. A.
Submitted on July 24, 2006
Accepted on November 13, 2006

A Genetic Model for the Chronic Activation of Skeletal Muscle AMP-activated Protein Kinase Leads to Glycogen Accumulation

Laura Barre1, Christine Richardson2, Michael F Hirshman3, Joseph T. Brozinick4, Steven Fiering5, Bruce E. Kemp6, Laurie J. Goodyear3, and Lee A. Witters7*

1 Medicine, Dartmouth Medical School, Hanover, New Hampshire, United States
2 Medicine, Dartmouth Medical School, Hanover, New Hampshire, United States; Hanover, New Hampshire, United States
3 Joslin Diabetes Center, Metabolism Section, Harvard Medical School, Boston, Massachusetts, United States
4 Eli Lilly and Company, Indianapolis, Indiana, United States
5 Immunology, Dartmouth Medical School, Hanover, New Hampshire, United States
6 St. Vincent's Institute of Medical Research, CSIRO Health Sciences and Nutrition, Australia
7 Department of Medicine, Endocrine-Metabolism Division, Dartmouth Medical School, Hanover, New Hampshire, United States

* To whom correspondence should be addressed. E-mail: lee.a.witters{at}dartmouth.edu.

The AMP-activated protein kinase (AMPK) is an important metabolic sensor/effector that coordinates many of the changes in mammalian tissues during variations in energy availability. We have sought to create an in vivo genetic model of chronic AMPK activation, selecting murine skeletal muscle as a representative tissue where AMPK plays important roles. Muscle-selective expression of a mutant non-catalytic {gamma}1 (R70Q{gamma}1) subunit of AMPK activates AMPK and increases muscle glycogen content. The increase in glycogen content requires the presence of the endogenous AMPK catalytic {alpha} subunit, since the offspring of cross breeding of these mice with mice expressing a dominant-negative AMPK {alpha} subunit have normal glycogen content. In R70Q {gamma}1-expressing mice, there is a small, but significant, increase in muscle glycogen synthase (GSY) activity associated with an increase in the muscle expression of the liver isoform, GSY2. The increase in glycogen content is accompanied, as might be expected, by an increase in exercise capacity. Transgene expression of this mutant AMPK{gamma}-1 subunit may provide a useful model for the chronic activation of AMPK in other tissues to clarify its multiple roles in the regulation of metabolism and other physiologic processes.




This article has been cited by other articles:


Home page
 NEJMHome page
L. J. Goodyear
The Exercise Pill -- Too Good to Be True?
N. Engl. J. Med., October 23, 2008; 359(17): 1842 - 1844.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Folmes, L. A. Witters, M. F. Allard, M. E. Young, and J. R. B. Dyck
The AMPK {gamma}1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3456 - H3464.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.